These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30179652)

  • 1. Effects of angiotensin-(1-7) and angiotensin II on vascular tone in human cirrhotic splanchnic vessels.
    Casey S; Herath C; Rajapaksha I; Jones R; Angus P
    Peptides; 2018 Oct; 108():25-33. PubMed ID: 30179652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
    Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
    Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients.
    Vilas-Boas WW; Ribeiro-Oliveira A; Ribeiro Rda C; Vieira RL; Almeida J; Nadu AP; Simões e Silva AC; Santos RA
    World J Gastroenterol; 2008 Nov; 14(44):6824-30. PubMed ID: 19058308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics.
    Gunarathne LS; Rajapaksha H; Shackel N; Angus PW; Herath CB
    World J Gastroenterol; 2020 Oct; 26(40):6111-6140. PubMed ID: 33177789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension.
    Shim KY; Eom YW; Kim MY; Kang SH; Baik SK
    Korean J Intern Med; 2018 May; 33(3):453-461. PubMed ID: 29462546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the Alternate Renin-Angiotensin System Correlates with the Clinical Status in Human Cirrhosis and Corrects Post Liver Transplantation.
    Casey S; Schierwagen R; Mak KY; Klein S; Uschner F; Jansen C; Praktiknjo M; Meyer C; Thomas D; Herath C; Jones R; Trebicka J; Angus P
    J Clin Med; 2019 Mar; 8(4):. PubMed ID: 30934723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of Mas Receptor or Mas-Related G-Protein Coupled Receptor Type D Reduces Portal Pressure in Cirrhotic but Not in Non-cirrhotic Portal Hypertensive Rats.
    Gunarathne LS; Angus PW; Herath CB
    Front Physiol; 2019; 10():1169. PubMed ID: 31607942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis.
    Heller J; Trebicka J; Shiozawa T; Schepke M; Neef M; Hennenberg M; Sauerbruch T
    Liver Int; 2005 Jun; 25(3):657-66. PubMed ID: 15910503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis.
    Vilas-Boas WW; Ribeiro-Oliveira A; Pereira RM; Ribeiro Rda C; Almeida J; Nadu AP; Simões e Silva AC; dos Santos RA
    World J Gastroenterol; 2009 May; 15(20):2512-9. PubMed ID: 19469002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options.
    Grace JA; Herath CB; Mak KY; Burrell LM; Angus PW
    Clin Sci (Lond); 2012 Aug; 123(4):225-39. PubMed ID: 22548407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
    Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
    Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options.
    Rajapaksha IG; Gunarathne LS; Angus PW; Herath CB
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33670126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.
    Lubel JS; Herath CB; Tchongue J; Grace J; Jia Z; Spencer K; Casley D; Crowley P; Sievert W; Burrell LM; Angus PW
    Clin Sci (Lond); 2009 Sep; 117(11):375-86. PubMed ID: 19371232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver.
    Herath CB; Mak K; Burrell LM; Angus PW
    Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G99-108. PubMed ID: 23086915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2.
    Paizis G; Tikellis C; Cooper ME; Schembri JM; Lew RA; Smith AI; Shaw T; Warner FJ; Zuilli A; Burrell LM; Angus PW
    Gut; 2005 Dec; 54(12):1790-6. PubMed ID: 16166274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis.
    Helmy A; Jalan R; Newby DE; Hayes PC; Webb DJ
    Gastroenterology; 2000 Mar; 118(3):565-72. PubMed ID: 10702208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic and splanchnic nitric oxide activity in patients with cirrhosis.
    Sarela AI; Mihaimeed FM; Batten JJ; Davidson BR; Mathie RT
    Gut; 1999 May; 44(5):749-53. PubMed ID: 10205218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing Effect of Biejiajian Oral Liquid () on ACE-Ang II-AT1R Axis and ACE2-Ang-(1-7)-Mas Axis in Rats with CCl
    Li XY; Peng Y; Bu XW; Yao J; Yao L
    Chin J Integr Med; 2018 Nov; 24(11):853-859. PubMed ID: 29335866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins.
    Hennenberg M; Trebicka J; Biecker E; Schepke M; Sauerbruch T; Heller J
    Hepatology; 2007 Feb; 45(2):495-506. PubMed ID: 17256744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis.
    Di Pascoli M; Sacerdoti D; Pontisso P; Angeli P; Bolognesi M
    J Vasc Res; 2017; 54(2):92-99. PubMed ID: 28402977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.